DON'T BUY
His model is $22.32 or -60%. Maybe over time the stock price and the earnings come together.
BUY ON WEAKNESS
He would be a buyer here because it is one of the top 100 S&P. His model price is $144.21 or a 24% upside.
HOLD
Model price is $177.47, and it is 38% above that, but you can't sell this thing. Hold it if you are. He thinks it goes to $317 and holds there for a while.
HOLD
He would not buy more. Wait for the new balance sheet. It is one of the top 30 systemic banks in the world. The US banks are a lot cheaper. Canadian banks are the most expensive in the world. Buy it if it comes back to $62.
PARTIAL BUY
We have not had a correction in this for a year. This is a good on a pull back. His model price is 182.22 or 8% lower than it is now. It will go higher if it goes up in a US melt-up. Buy a little bit here.
BUY ON WEAKNESS
He likes it and owns it personally. They have a great niche product. $49.58 is his model price. It is in a big sideways pattern.
TOP PICK
It is the cheapest it has been since 1995. 5% yield; one of the best companies in the world and at a cheap price. (Analysts’ price target is $78.16)
TOP PICK
The drug space all have huge upsides. He has owned it for quite some time. Model rice is $185.42 which is a 33% upside. There is a lot of value here. (Analysts’ price target is $150.39)
TOP PICK
Model price of $115.23 which is an 8% upside. This is a solid company. (Analysts’ price target is $106.06)
COMMENT
Tonight's show was a repeat program from the Wednesday, December 4 MCT.